{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:38Z","timestamp":1790794178559,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ALK"},{"name":"Astra Zeneca"},{"name":"Boeringher Ingelheim"},{"name":"GSK"},{"name":"Le Nouveau Souffle"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In France, data regarding epidemiology and management of severe asthma are scarce. The objective of this study was to describe asthma phenotypes using a cluster analysis in severe asthmatics recruited in a real world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study design was prospective, observational and multicentric. The patients included were adults with severe asthma (GINA 4\u20135) followed-up in French Non Academic Hospital between May 2016 and June 2017. One hundred and seven physicians included 1502 patients. Both sociodemographic and clinical variables were collected. Hierarchical cluster analysis was performed by the Ward method followed by k-means cluster analysis on a population of 1424 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five clusters were identified: cluster 1 (n\u2009=\u2009690, 47%) called early onset allergic asthma (47.5% with asthma before 12\u00a0years), cluster 2 (n\u2009=\u2009153, 10.5%): obese asthma (63.5% with BMI\u2009&gt;\u200930\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), cluster 3 (n\u2009=\u2009299, 20.4%): late-onset asthma with severe obstructive syndrome (89% without atopy), cluster 4 (n\u2009=\u2009143, 9.8%): eosinophilic asthma (51.7% had more than 500 eosinophils\/mm\n                      <jats:sup>3<\/jats:sup>\n                      ), and cluster 5 (n\u2009=\u2009139, 9.5%): aspirin sensitivity asthma (63% had severe asthma attacks).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In our population of adults with severe asthma followed by pulmonologists, five distinct phenotypes were identified and are quite different from those mentioned in previous studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-021-01723-x","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T16:03:06Z","timestamp":1620144186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["FASE-CPHG Study: identification of asthma phenotypes in the French Severe Asthma Study using cluster analysis"],"prefix":"10.1186","volume":"22","author":[{"name":"The CPHG (College of French Non-academic Hospitals)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-2883","authenticated-orcid":false,"given":"Chantal","family":"Raherison-Semjen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Parrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Nocent-Eijnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Mangiapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Prudhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Aperre de Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Debieuvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Portel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"1723_CR1","unstructured":"Global Strategy for Asthma Management and Prevention, Revised 20182018; www.ginasthma.org: 2018 Global Initiative for Asthma."},{"key":"1723_CR2","doi-asserted-by":"crossref","unstructured":"The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003;22(3):470\u20137.","DOI":"10.1183\/09031936.03.00261903"},{"issue":"4","key":"1723_CR3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jaip.2017.05.015","volume":"5","author":"AM Fitzpatrick","year":"2017","unstructured":"Fitzpatrick AM, Moore WC. Severe asthma phenotypes\u2014how should they guide evaluation and treatment? J Allergy Clin Immunol Pract. 2017;5(4):901\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"1723_CR4","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jaci.2013.10.006","volume":"133","author":"M Schatz","year":"2014","unstructured":"Schatz M, Hsu JW, Zeiger RS, Chen W, Dorenbaum A, Chipps BE, et al. Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2014;133(6):1549\u201356.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1723_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/thx.2010.137414","volume":"65","author":"LG Heaney","year":"2010","unstructured":"Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM. British Thoracic Society difficult asthma N. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax. 2010;65(9):787\u201394.","journal-title":"Thorax"},{"issue":"12","key":"1723_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.rmed.2014.10.007","volume":"108","author":"F Schleich","year":"2014","unstructured":"Schleich F, Brusselle G, Louis R, Vandenplas O, Michils A, Pilette C, et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med. 2014;108(12):1723\u201332.","journal-title":"Respir Med."},{"issue":"3","key":"1723_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/all.13342","volume":"73","author":"S Maio","year":"2018","unstructured":"Maio S, Baldacci S, Bresciani M, Simoni M, Latorre M, Murgia N, et al. RItA: the Italian severe\/uncontrolled asthma registry. Allergy. 2018;73(3):683\u201395.","journal-title":"Allergy"},{"key":"1723_CR8","doi-asserted-by":"publisher","unstructured":"Fabry-Vendrand C, Didier A. Asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey. Eur Respir J. 2018;52(Suppl62):OA292. https:\/\/doi.org\/10.1183\/13993003.congress-2018.OA292.","DOI":"10.1183\/13993003.congress-2018.OA292"},{"issue":"4","key":"1723_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","volume":"135","author":"PP Hekking","year":"2015","unstructured":"Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896\u2013902.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1723_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","volume":"2","author":"A von Bulow","year":"2014","unstructured":"von Bulow A, Kriegbaum M, Backer V, Porsbjerg C. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759\u201367.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1723_CR11","doi-asserted-by":"publisher","unstructured":"Brown T, Jones T, Gove K, Barber C, Elliott S, Chauhan A, et al. Randomised controlled trials in severe asthma: selection by phenotype or stereotype. Eur Respir J. 2018;52(6):1801444. https:\/\/doi.org\/10.1183\/13993003.01444-2018.","DOI":"10.1183\/13993003.01444-2018"},{"key":"1723_CR12","doi-asserted-by":"publisher","unstructured":"Portel L, Parrat E, Nocent-Ejnaini C, Mangiapan G, Prud'homme A, Oster JP, et al. FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals. ERJ Open Res. 2019;5(4):00069-2019. https:\/\/doi.org\/10.1183\/23120541.00069-2019.","DOI":"10.1183\/23120541.00069-2019"},{"key":"1723_CR13","doi-asserted-by":"crossref","unstructured":"Eileen W, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR). Chest. 2019;157(4):790\u2013804.","DOI":"10.1016\/j.chest.2019.10.053"},{"key":"1723_CR14","doi-asserted-by":"publisher","unstructured":"van Bragt J, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, et al. Characteristics and treatment regimens across ERS SHARP severe asthma registries. Eur Respir J. 2019;54(Suppl63):OA5354. https:\/\/doi.org\/10.1183\/13993003.congress-2019.OA5354","DOI":"10.1183\/13993003.congress-2019.OA5354"},{"issue":"5","key":"1723_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/all.12136","volume":"68","author":"M Amelink","year":"2013","unstructured":"Amelink M, de Nijs SB, de Groot JC, van Tilburg PM, van Spiegel PI, Krouwels FH, et al. Three phenotypes of adult-onset asthma. Allergy. 2013;68(5):674\u201380.","journal-title":"Allergy"},{"issue":"7","key":"1723_CR16","doi-asserted-by":"publisher","first-page":"e102987","DOI":"10.1371\/journal.pone.0102987","volume":"9","author":"C Newby","year":"2014","unstructured":"Newby C, Heaney LG, Menzies-Gow A, Niven RM, Mansur A, Bucknall C, et al. Statistical cluster analysis of the British Thoracic Society Severe refractory Asthma Registry: clinical outcomes and phenotype stability. PLoS ONE. 2014;9(7):e102987.","journal-title":"PLoS ONE"},{"issue":"4","key":"1723_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thoraxjnl-2015-207630","volume":"71","author":"J Sweeney","year":"2016","unstructured":"Sweeney J, Patterson CC, Menzies-Gow A, Niven RM, Mansur AH, Bucknall C, et al. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry. Thorax. 2016;71(4):339\u201346.","journal-title":"Thorax"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-021-01723-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01723-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T03:04:51Z","timestamp":1620183891000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-021-01723-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1186\/s12931-021-01723-x","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"28 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethics committee (Comit\u00e9 Consultatif sur le Traitement de l\u2019Information en mati\u00e8re de Recherche dans le domaine de la Sant\u00e9 (CCTIRS)) and was conducted according to the French law and guidelines on epidemiological and descriptive studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}